Delivery Order SPE2DB24D3015-SPE2DB25FGASE
Award Date 8/22/25
Potential Completion Date 8/25/25
Potential Value $3.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Myfembree (40 mg, 1 mg, and 0.5 mg tablets) in a quantity of 28 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $2,149.77 and is scheduled for completion by September 9, 2025. The contract represents a non-set-aside procurement, indicating AmerisourceBergen's competitive selection among qualified vendors....
- The U.S. Defense Logistics Agency (DLA) awarded a $3,217.50 Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S medication. The contract has an ultimate completion date of May 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,345.79 firm fixed-price delivery order contract, with a completion date of January 8, 2025, is for the supply of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a pharmaceutical product. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of the pharmaceutical product MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S. The contract is a Delivery Order with a Firm Fixed Price of $2,190.63, and has an Ultimate Completion Date of June 9, 2025. The award was made by the Defense Logistics Agency, a Defense agency, on June 6, 2025. This contract is not set-aside and is open to full and open...
- This is a $3,891.46 firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract is to provide MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, which are likely specialty pharmaceutical products, to support military healthcare programs. The award does not have a set-aside designation, indicating open competition....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $17,524.44 to AmerisourceBergen Drug Corp on July 27, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- The Defense Logistics Agency Medical Supply Chain awarded a $3,370.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded contract, issued without set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The vendor...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a firm fixed-price delivery order valued at $33,210.08 to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $33,204 firm fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on September 1, 2025, with completion scheduled for September 2, 2025. This non-set-aside, competitively awarded contract represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through...
- The Defense Logistics Agency's Medical Supply Chain awarded a $3,562.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 28, 2025, with completion expected by August 29, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion vehicle running through December 2026. The delivery order was fulfilled from AmerisourceBergen's Corporate Office...